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Age patterns of survival and fertility vary widely across 
species   [1].   During  evolution,   natural  selection  has  
 
 

















































shaped these age patterns, referred to as life histories, so 
to optimise the fitness of each species by maximising 
reproduction [2]. Reproduction is increased if survival 
or fertility are enhanced or if a decline in survival or 
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As an explanation, such genetic determinants have been selected  in adverse environments,  in which humans have  lived
during most of their history, but are almost exclusively studied in populations in modern affluent environments. Here, we
present a  large‐scale candidate gene association study  in a rural African population  living  in an adverse environment.  In
4387  individuals, we  studied 4052  SNPs  in 148  genes  that have previously been  identified as possible determinants of




we  hypothesise  that  genetic  heterogeneity  of  complex  phenotypes  and gene ‐environment interactions  prevent the
identification of genetic variants explaining variation in survival and fertility in humans. 
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fertility with age is resisted. The diversity in life history 
across species indicates that it has a strong genetic 
basis. Several genetic pathways have been found in 
animals that regulate survival and fertility, including the 
signalling cascade of growth hormone (GH), insulin-
like growth factor 1 (IGF1), and insulin, signalling by 
target of rapamycin (TOR), DNA repair mechanisms, 
immune regulation, and telomere maintenance [3, 4]. 
These pathways have been discovered mostly in studies 
on mutant animal models, but likely contribute to 
variation in survival and fertility in wild-type animals as 
well [5, 6]. Genetic variation in these pathways is 
thought to likewise determine the age patterns of 
survival and fertility in humans [7], but it remains 
disappointingly inconclusive as an explanation of 
observed variation in human survival and fertility. 
Candidate-gene studies, linkage studies, and genome-
wide association studies have yielded consistent 
evidence for only a handful of genetic variants to 
determine variation in human survival to old age, of 
which most notably APOE [8-11]. Genetic variants have 
been described as determinants of human infertility [12, 
13], but have rarely been studied for variation in human 
fertility [14]. 
 
Research on the genetic determinants of human life 
history has almost exclusively been conducted in 
populations living in modern affluent environments. 
These modern affluent environments, however, are 
radically different from the environments in which over 
many generations humans have been subjected to 
evolutionary pressures. During most of human history, 
survival and fertility were compromised by infectious 
diseases [15, 16], malnutrition [17, 18], climatic 
hardships, predation, and violence [19]. Fitness, which 
includes survival and fertility, has long been shaped by 
natural selection enforced through these environmental 
stressors. It is, therefore, likely that natural selection has 
enhanced survival and fertility by promoting genetic 
variants that shape inflammatory processes to improve 
resistance against infections, metabolic processes to 
facilitate consumption and storage of nutrients, and 
psychological strategies to cope with environmental 
stressors. In modern affluent environments, however, 
where survival and fertility depend less on these adverse 
environmental stressors, such genetic variants are of 
less influence on life history. 
 
If we aim to identify the genetic determinants of life 
history that have enhanced fitness in adverse 
environments, we should search for them in such 
environments. In this study, we investigate genetic 
variants that determine life history through variation in 
survival and fertility in a traditional rural African 
population that lives in such an adverse environment. 
Compared with modern affluent environments, this 
population’s mortality rates and fertility rates are high, 
various infectious diseases are endemic, periodic food 
shortage and malnutrition are common, and a sedentary 




Table 1 shows the general characteristics of the 
Ghanaian study population. Genetic variants as 
determinants of variation in survival were investigated 
in men and women together, grouped as newborns, 
middle-aged adults of fertile ages from 20 through 44 
years, and old individuals aged 60 years or over. 
Genetic variants as determinants of variation in fertility 
were investigated in women only. Observed fertility 
was registered in middle-aged women of fertile ages 
from 20 through 44 years during follow-up. Reported 
fertility was registered in postmenopausal women aged 
45 years or over at the beginning of follow-up. 
 
As shown in Figure 1, after the quality control 4052 
SNPs, encompassing 148 genes, were included in the 
analyses. The median (interquartile range) number of kb 
between SNPs included in the analyses was 2.3 kb (1.8-
3.4 kb). An overview of the included genes is given in 
Supplementary Table 1. 
 
Figure 2 reports on the investigation of the genetic 
variants as determinants of variation in survival. We 
assessed the association of each SNP with the chance of 
being an old individual as compared with a newborn, a 
middle-aged adult as compared with a newborn, and an 
old individual as compared with a middle-aged adult, 
reflecting the survival between each pair of age groups. 
None of the SNPs were statistically significantly 
associated with survival between these three age groups. 
 
Although each was non-significant, we list the ten SNPs 
with the lowest p values for the association with 
survival between each pair of age groups in 
Supplementary Tables 2, 3, and 4. SNPs in many 
different genes appeared in these lists, among which 
two neutrally selected control SNPs in the list 
comparing newborns and old individuals. None of these 
SNPs appeared in more than one of these lists, except 
for rs2026816 in the insulin receptor substrate 2 gene 
(IRS2) and rs2069842 in the interleukin 6 gene (IL6), 
both of which were in the lists comparing newborns and 
old individuals and comparing newborns and middle-
aged adults. 
 
Figure 3 reports on the investigation of the genetic 
variants as determinants of variation in fertility. We 
assessed the associations of each SNP with observed 
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fertility in middle-aged women and with reported 





















































were statistically significantly associated with either 
























































 Men and women  Women 
 0 years 20-44 years ≥ 60 years  20-44 years ≥ 45 years 
Individuals, n 1482 1589 1144  732 708 
Females, n (%) 695 (46.9) 1394 (87.7) 608 (53.1)  732 (100.0) 708 (100.0) 
Age, years 0 (0–0) 33 (26–40) 70 (65–77)  33 (27–37) 63 (56–71) 
Tribe, n (%)       
     Bimoba 1017 (68.6) 1124 (70.7) 696 (60.8)  549 (75.0) 446 (63.0) 
     Kusasi 367 (24.8) 365 (23.0) 357 (31.2)  142 (19.4) 205 (29.0) 
     Other 98 (6.6) 100 (6.3) 91 (8.0)  41 (5.6) 57 (8.1) 
Observed fertility NA NA NA  1 (1–2) NA 
Reported fertility NA NA NA  NA 8 (6–9) 
Data  are  given  as  numbers with  percentages  or  as medians with  interquartile  ranges.  Observed  fertility  is 
























































Although each was non-significant, we list the ten SNPs 
with the lowest p values for the associations with 
observed and reported fertility in Supplementary Tables 




















































lists. Among them was a neutrally selected control SNP 
in the list for the association with observed fertility in 
middle-aged women. None of the SNPs appeared in 
both lists. 
Figure  2.  Manhattan  plots  assessing  the  associations  of  SNPs  with  survival.  (A)  Manhattan  plot
assessing the associations of SNPs with survival between newborns and old  individuals aged 60 years or over.
(B) Manhattan plot assessing the associations of SNPs with survival between newborns and middle‐aged adults








































The aim of this study was to identify the genetic 
variants that determine life history through variation in 
survival and fertility in a traditional rural African 
population that lives in an adverse environment without 
a western lifestyle. We conducted a large-scale 
candidate gene study using a high density of SNPs. We 
found no statistically significant association of any 
genetic variant with either survival or fertility. 
 
Studies on the genetic determinants of variation in 
human survival and fertility in adverse environments 
have never been executed with numbers of individuals 
and SNPs comparable to this study. Due to a lack of 
previous genetic studies in this region, we could not rely 
on standard genome-wide association analyses given the 
higher degree of population stratification and the lesser 
degree of linkage disequilibrium in African populations 




































typing a high density of SNPs in the genes of interest. A 
relatively large proportion of SNPs failed genotyping or 
had an insufficient minor allele frequency. The 
exceptional circumstances that are inherent to adverse 
environments – such as an inadequate infrastructure, a 
missing civil registry, and language and culture barriers 
– compromised the study’s execution. The proportion of 
individuals with failed genotyping was comparable with 
studies in western affluent environments, but we rigidly 
excluded a relatively large proportion that appeared to 
have a mismatch between their genetic and registered 
sexes or to be unintentionally duplicated. To enlarge the 
contrast in the analysis of the SNPs’ associations with 
survival the selection of old individuals could have been 
restricted to higher ages, but this would have 
diminished the number of included old individuals and 
the power of the analysis. A post hoc calculation of the 
present study’s power, based on the numbers of 
individuals and SNPs included in the analyses after the 
quality control using an additive logistic regression 
Figure 3. Manhattan plots assessing the associations of SNPs with fertility in women. (A) Manhattan plot assessing
the associations of SNPs with observed fertility in middle‐aged women of fertile ages from 20 through 44 years. The level of
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model, reveals that we could find statistically significant 
associations with an odds ratio of at least 1.4 with a 
power of 80% and a minimal minor allele frequency 
ranging from 0.08 to 0.29 (Supplementary Figure 1). As 
we did not find such statistically significant 
associations, the associations are possibly present, but 
less strong. 
 
Population stratification was unlikely to explain our 
results. As a result of the polygynous and patrilocal 
culture in the research area, men preferentially marry 
women from outside the region. Previous analyses of 
this study population have confirmed that the female-
mediated gene flow is nearly fully random and prevents 
population stratification of autosomal genes [31]. To 
account for possible population stratification in this 
study, we rigidly excluded individuals that had a 
different allele at less than 10% of the loci indicated by 
an IBS1 below 10% and SNPs that were not in Hardy-
Weinberg equilibrium. In addition, we adjusted our 
analyses for tribe, which represents a mainly cultural 
population stratification, and for the main dimensions of 
the multidimensional scaling (MDS) analysis, which 
represents a mainly genetic population stratification. 
The MDS analysis did not reveal any population 
stratification. The adjustments did not affect our results. 
 
Here we did not find genetic variants that were 
statistically significantly associated with variation in 
survival or fertility. This finding corresponds with the 
difficulty to identify such variants in modern affluent 
environments. In such environments, variation in human 
lifespan is genetically determined for only less than 
30%. Many and various studies have yielded consistent 
evidence for only a handful of genetic variants to 
determine variation in survival, most notably APOE, 
and most of their associations with survival are not 
strong [8-10]. Genetic variants that determine infertility 
have been identified, but genetic variants that determine 
variation in fertility have rarely been reported [14]. 
These disappointing results have been explained by the 
proposition that survival and fertility are determined by 
rare genetic variants with a strong effect or by a 
complex of interacting genetic variants with small 
effects. Both remain undetected in genome-wide or 
large-scale candidate gene association studies, such as 
our study [10, 11]. 
 
Contrary to many studies in affluent populations, the 
present study did not identify APOE as a determinant of 
variation in survival. Three SNPs in APOE were 
included in the present analyses: rs1081101, rs877973, 
and rs769450. The p values for their associations with 
survival ranged between 0.36 and 1.00. In West 
Africans, only the latter of these SNPs is in linkage 
disequilibrium (r2=0.21) with rs429358, the SNP that 
constitutes the APOEε4 allele and most consistently 
determines variation in survival in modern affluent 
populations, but contrary to rs429358, it does not 
influence blood lipid levels. The other two SNPs are not 
in linkage disequilibrium with rs429358 and influence 
blood triglyceride, but not cholesterol levels [32]. 
 
Our finding that genetic variants known to influence 
survival in modern affluent populations, such as APOE, 
did not influence survival in adverse environments may 
likely be explained, apart from chance, by gene-
environment interaction. The effects of genes vary 
depending on environmental conditions, which thus 
determine the effects of genes on survival and fertility 
[33]. Our study was conducted in an environment 
characterised by endemic infectious diseases, shortages 
of food, necessary physical activity, and a scarcity of 
cardiovascular disease and diabetes up to high ages [20-
29]. These characteristics differ radically from those of 
modern affluent environments. Variants of APOE affect 
blood lipid levels, the risk of cardiovascular disease, 
and survival in affluent populations [34]. In this study 
population, lipid levels as well as the risk of 
cardiovascular disease are far lower than in affluent 
populations [25-28], which may explain why APOE 
does not affect survival here. The higher levels of 
physical activity may provide an additional explanation 
for the absence of such an effect [35]. Likewise, we 
have previously shown that variants of IL10, associated 
with the inflammatory strength of the immune response, 
enhance survival in those exposed to contaminated 
drinking water, but diminish survival in those exposed 
to clean drinking water [36]. These examples of 
different effects of genetic variants in different 
environments indicate that such effects can only be 
identified if, firstly, a specific hypothesis is formulated, 
secondly, the environmental conditions are measured 
with the same rigour as the genetic variants, and, 
thirdly, corresponding appropriate statistical methods 
are applied. 
 
Life histories have evolved as natural selection has 
optimised fitness by increasing the frequencies of genetic 
variants that enhance survival and fertility, while 
decreasing the frequencies of genetic variants that 
diminish survival and fertility. The effects of genetic 
variants on survival and fertility, and thereby the 
evolution of life history, are largely dependent on 
environmental factors [2]. The diversity in life history 
across species indicates that it has a genetic basis, but the 
diversity in the genetic variants that determine variation 
in survival and fertility across populations and environ-
ments within species indicates that these genetic variants 
differ across species, populations, and environments. 
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Evolutionary theory predicts that most of the genetic 
variants that enhance survival diminish fertility or vice 
versa, because a trade-off exists between investments in 
survival and investments in fertility [37, 38]. Indeed, 
genetic variants have been described that influence both 
survival and fertility [39, 40]. The close relation 
between survival and fertility during evolution has 
encouraged us to study them jointly. Furthermore, 
several evolutionary theories explain why survival and 
fertility decline with age in humans and many other 
species. According to one theory, random damage 
accumulates in the genetic determinants of survival and 
fertility as natural selection loses its strength [37, 38]. 
Such genetic damage as determinants of life history that 
differ across individuals cannot be identified by a study 
like the present. According to another theory, some 
genetic determinants that enhance survival and fertility 
at early ages have an antagonistic pleiotropic effects 
that diminish survival and fertility at later ages [37, 38]. 
The present study would have been able to identify such 
genetic determinants. 
 
It is critical to acknowledge that natural selection works 
to maximize fitness as a phenotype rather than a 
genotype, with survival and fertility being the most 
important components of this phenotype. The genotype 
only matters to natural selection as a determinant of the 
phenotype that is under selection. Meanwhile, the 
phenotype may be the result of a complex interaction 
between various genetic variants. Natural selection 
exists by virtue of such variation in the genetic 
determinants. Genetic variation is conserved, since 
genes are prone to mutations and new genetic variants 
are introduced by sexual reproduction. The resulting 
genetic heterogeneity of populations may explain why 
so few unique genetic variants have been found to 
determine variation in the complex phenotypes of 
survival and fertility. If different genetic variants 
determine a similar phenotype, each of these genetic 
variants is shared by only a proportion of the 
individuals and a patchwork of shared and unshared 
variants is established throughout the population. 
Moreover, if different genetic variants interact with 
each other to express a phenotype, the penetrance of one 
of these genetic variants relative to another may vary 
throughout the population. When studied in a 
population as a whole, these patterns lead to annulation 
of the effect of a single genetic variant. As an example 
of genetic heterogeneity underlying a single phenotype, 
the ability to digest milk after childhood due to lactase 
persistence has independently evolved multiple times in 
similar environments of animal domestication. Across 
populations, various SNPs at different positions in the 
lactase gene bring about this trait. Still, these specific 
variants are insufficient to explain differences in the 
frequencies of lactase persistence across populations 
[41, 42]. Methods to analyse multiple interacting 
genetic variants are possible, but beyond the aim of this 
study. More fundamentally, the complexity of the 
genotype to give rise to a phenotype suggests that, next 
to explaining genetic variation in survival and fertility, 
it may be more worthwhile to search for the causal 
biological mechanisms that determine survival and 
fertility. 
 
In conclusion, we aimed to identify the genetic variants 
that determine life history through variation in survival 
and fertility in an adverse environment in rural Africa, 
which resembles the environments during most of 
recent human evolution. In this large-scale candidate 
gene study, we did not find statistically significant 
associations of genetic variants with survival or fertility. 
Apart from a lack of power, we hypothesise that genetic 
heterogeneity of complex phenotypes and gene-
environment interaction prevent the identification of 





Study population. This study was conducted in the 
Garu-Tempane District in the Upper East Region in 
Ghana. The region is rural, remote, and one of the least 
developed in the country. The vast majority of the 
inhabitants are involved in subsistence agriculture 
performed by manual labour without proper means of 
transportation or mechanized farming. The mean annual 
per capita income and expenditure in the region are one 
third of those in Ghana nationally and one fifth of those 
in the capital Accra [43]. Of the adult inhabitants, 31% 
has attended school as compared with 69% in Ghana 
nationally and 89% in the capital Accra [43]. Hospital 
care is absent. Various infectious diseases – including 
malaria, measles, meningitis, tuberculosis, typhoid 
fever, trachoma, and intestinal helminths – are highly 
endemic and constitute the main causes of death both in 
childhood and adulthood, although the prevalence of 
human immunodeficiency virus (HIV) is low (<4%) 
compared with other African regions [44]. 
 
From 2002 through 2011, we kept a demographic 
registry of the population in a research area of 375 km2 
comprising 32 villages. During annual visits we 
registered the name, age, sex, tribe, and location of 
living of each inhabitant. If an inhabitant’s age was 
unknown, it was estimated by oral methods, as 
described previously [20, 21]. Households were 
occupied by extended families with 48% of the married 
men having multiple wives [45]. Annual migration 
relative to the study population’s size was 2% into and 
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1% out of the research area. The average property of the 
households included small numbers of cattle and 
bicycles with a value of circa 1,000 US$ and 15% of the 
households had access to electricity [22, 45]. Drinking 
water was drawn from boreholes, open wells, and rivers 
[36]. Of apparently healthy adults, 86% were infected 
by the malaria species Plasmodium falciparum, 44% by 
the protozoan Giardia lamblia, and 31% by the 
helminth Necator americanus [24]. During the nine 
years of follow-up, 46 to 53% of the population was 
aged less than 15 years and 6 to 7% of the population 
was aged 60 years and more [28]. 
 
Ethical approval was given by the Committee Medical 
Ethics of the Leiden University Medical Center, the 
Ethical Review Committee of Ghana Health Services, 
and the local chiefs and elders. Because of illiteracy, 
informed consent was obtained orally from the 
participants after explanation of the purpose and 
conduction of this research project. The data were 
analysed anonymously. This study was conducted in 
accordance with the Declaration of Helsinki. 
 
Survival and fertility. Survival of all inhabitants was 
registered during the annual follow-up from 2002 
through 2011 [28]. Fertility of women was measured 
through their reproduction in two manners. Firstly, 
observed fertility was registered prospectively for 
women of all ages during the annual follow-up from 
2002 through 2011. Observed fertility was expressed as 
the number of children that a woman gave birth to 
during the period of follow-up [28, 46]. Secondly, 
reported fertility was retrospectively determined in 2003 
by interviewing women who were available and willing 
to participate. Data on reported fertility was restricted to 
women aged 45 years and older, who were considered 
to be postmenopausal and for whom reported fertility 
represented lifelong reproduction. Reported fertility was 
expressed as the number of children that a woman had 
given birth to during life [21, 47]. 
 
DNA collection, isolation, processing, and genotyping. 
To identify genetic variants associated with survival, we 
aimed to contrast the genotypes of newborns, of middle-
aged individuals, and of individuals who had survived 
to old age. To identify genetic variants associated with 
fertility, we aimed to associate the genotypes of middle-
aged and postmenopausal women with their reported or 
observed fertility. Since 2003, we took buccal samples 
from all newborns who were present during our visits, 
older than one week, and born in the same year. We 
took buccal samples from men and women of the fertile 
ages from 20 through 44 years, from women aged 45 
years and older, and from men and women aged 60 
years and older. The buccal samples of middle-aged and 
older individuals were collected together with 
measurements of phenotypic characteristics, including 
fertility [21, 47], infectious diseases [24], inflammatory 
and metabolic markers in blood [23, 25, 26, 36], 
cardiovascular health [25-27], muscle strength [29, 48]. 
These characteristics had been measured in randomly 
selected individuals. In addition, we collected buccal 
samples in 2010 from individuals randomly selected 
from our demographic registry to obtain balanced 
numbers in the three age groups. With an eye to the 
analyses of fertility, we oversampled middle-aged 
women over men. 
 
The buccal samples were stored in 2.5 ml STE buffer 
(100 mM NaCl, 10 mM Tris/HCl, 10 mM EDTA, pH 
8.0) with 0.05 mg/ml proteinase K, 0.1 mg/ml pronase, 
and 0.5% sodium dodecylsulphate. DNA was isolated 
and processed from samples collected in 2002 through 
2006 by BaseClear (Leiden, the Netherlands) using a 
Chemagic bead-extraction method, from samples 
collected in 2006 through 2008 by the Department of 
Molecular Epidemiology of Leiden University Medical 
Center (Leiden, the Netherlands) using Qiagen silica 
spin-columns, and from samples collected in 2007 
through 2011 by LGC Genomics, formerly KBioscience 
(Middlesex, UK), using a proprietary silica column 
method. DNA was genotyped using a custom-made 
Illumina Infinium iSelect High-Density Custom 
Genotyping BeadChip (Illumina, San Diego, CA) at the 
Department of Human Genetics of Leiden University 
Medical Center following the manufacturer’s 
instructions. 
 
Candidate gene selection. For the genotyping and 
analyses, we selected 153 candidate genes that were 
considered relevant for regulation of life history based 
on literature, discussion with experts, and general 
inference. These candidate genes included genes 
associated with survival or fertility in genome-wide 
association studies in humans or model organisms [49], 
human genes that have been under positive or balancing 
selection pressure during the last 100,000 years and that 
are associated with survival or fertility [15, 50, 51], and 
homologues of genes associated with survival in model 
organisms [52]. 
 
SNP selection. We aimed for a dense coverage of SNPs 
in the candidate genes. We selected SNPs that are 
known to be causally associated with survival or 
fertility in humans, had a minor allele frequency equal 
to or higher than 1% and a correlation equal to or higher 
than 0.8 in the Yoruba population [53], and/or had a 
genotype score higher than 0.8 according to the 
Illumina Design Tool (Illumina, San Diego, CA). If 
necessary, we chose tag SNPs using Tagger [54] and/or 
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OpenHelix Genome Variation Server [55] based on the 
Yoruba population [53]. We additionally selected 170 
control SNPs that are presumed to be selectively neutral 
for analysis of population stratification [56, 57]. The 
median (interquartile range) number of 1000 base pairs 
(kb) between genotyped SNPs was 0.8 kb (0.8-1.0 kb). 
 
Quality control. After genotyping, buccal samples and 
SNPs were subjected to a stringent quality control 
protocol. Of the 6104 individuals from whom buccal 
samples had been taken, we excluded 370 (6.1%) 
because of genotyping failure. Furthermore, we 
excluded 98 (1.6%) individuals with a call rate below 
90%, 542 (8.9%) individuals with a sex mismatch, 3 (< 
0.1%) individuals with an excess of heterozygosity 
indicated by an inbreeding coefficient below -0.3 or 
above 0.3, and 492 (8.1%) individuals with a different 
allele at less than 10% of the loci indicated by an IBS1 
below 10%, which included unintentional duplicates. Of 
the 4599 individuals eligible for analysis, 212 (4.6%) 
individuals outside the designated sex and age groups 
were excluded. Of the 9509 genotyped SNPs, we 
excluded 1162 (12.2%) because of genotyping failure. 
Furthermore, we excluded 581 (6.1%) SNPs with a call 
rate below 90%, 3646 (38.3%) SNPs with a minor allele 
frequency below 1%, and 68 (0.7%) SNPs that were not 
in Hardy-Weinberg equilibrium. As a result, 4387 
individuals and 4052 SNPs were included in the 
analyses. Of these SNPs, 98 (2.4%) were evolutionarily 
neutrally selected controls. The exclusions and 
inclusions are described in Figure 1. 
 
As previously reported for this study population, 
population stratification is unlikely to influence any 
associations with genetic variation in autosomal genes. 
As a result of the polygynous and patrilocal culture in 
the research area, the female-mediated gene flow is 
nearly fully random [31]. Multidimensional scaling 
(MDS) analysis did not reveal any population 
stratification. Potential residual population stratification 
was addressed in the analyses. 
 
Analyses. For the investigation of the genetic 
determinants of survival, we assessed the association of 
each SNP with the chance of being in one of three age 
groups: newborns, middle-aged adults of fertile ages 
from 20 through 44 years, and old individuals aged 60 
years or over. We compared the chances between pairs 
of these groups using an additive logistic regression 
model adjusted for sex. For the investigation of the 
genetic determinants of fertility, we assessed the 
associations of each SNP with observed fertility in 
middle-aged women of fertile ages from 20 through 44 
years and with reported fertility in postmenopausal 
women aged 45 years and older. We assessed the 
association with reported fertility using an additive 
linear regression model. We assessed the association 
with observed fertility using an Andersen-Gill model, 
which is an extension to the Cox regression model for 
analysis of recurrent events [58]. The model was 
adjusted for calendar year in order to account for the 
decline in fertility observed during the period of follow-
up [28]. To avoid convergence of this model it was 
necessary to exclude 954 SNPs with a minor allele 
frequency below 5% from this assessment. All models 
were repeated with additional adjustment for tribe as a 
categorical covariate, with additional adjustment for the 
first two dimensions of the MDS analysis, with 
additional clustering per household, or with a 
combination of these in order to account for potential 
population stratification. These additional adjustments 
did not alter the results. After a Bonferroni correction 
for the number of SNPs included in the analyses the 
threshold for significant results was set at 1.23 × 10-5 
for the logistic and linear regression models and at 1.61 
× 10-5 for the Andersen-Gill model. The analyses were 
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14 AKT1 V-akt murine thymoma viral oncogene 
homolog 1 
10 3.1 
19 AKT1S1 AKT1 substrate 1 7 1.9 
22 APOBEC3G Apolipoprotein B mRNA editing enzyme 
catalytic polypeptide-like 3G 
4 3.9 
11 APOC3 Apolipoprotein C-III 5 1.6 
19 APOE Apolipoprotein E 3 2.9 
X AR Androgen receptor 36 5.2 
13 ARHGEF7 Rho guanine nucleotide exchange factor 7 98 2.0 
1 ARID1A AT rich interactive domain 1A 21 4.3 
21 BACH1 BTB and CNC homology 1, basic leucine 
zipper transcription factor 1 
73 4.5 
19 BRSK1 BR serine/threonine kinase 1 11 3.0 
16 CASKIN1 Calcium/calmodulin-dependent serine 
protein kinase (CASK) interacting protein 
1 
2 4.5 
3 CCR5 Chemokine (C-C motif) receptor 5 5 2.2 
X CD40LG CD40 ligand 6 2.9 
1 CD55 CD55 11 4.0 
7 CFTR Cystic fibrosis transmembrane 
conductance regulator 
3 64.6 
6 CGA Glycoprotein hormones α polypeptide 4 2.4 
11 CRACR2B Calcium release activated channel 
regulator 2B 
4 2.7 
16 CREBBP cAMP response element-binding protein 
(CREB) binding protein 
60 2.7 
1 DARC Duffy blood group 1 6.8 
6 DAXX Death-domain associated protein 2 4.7 
8 DEPDC6 DEP domain containing MTOR-
interacting protein 
112 1.6 
14 DIO2 Deiodinase iodothyronine type II 11 1.8 
  



























































































































14 DIO3 Deiodinase iodothyronine type III 0 NA 
15 DYX1C1 Dyslexia susceptibility 1 candidate 1 38 2.5 
4 EIF4E Eukaryotic translation initiation factor 4E 33 1.7 
8 EIF4EBP1 Eukaryotic translation initiation factor 4E 
binding protein 1 
9 3.9 
3 EPHA3 Ephrin receptor A3 4 93.7 
19 EPOR Erythropoietin receptor 3 3.8 
6 ESR1 Estrogen receptor α 164 2.5 
14 ESR2 Estrogen receptor β 51 2.3 
20 FKBP1A Tacrolimus binding protein 1A 20 1.5 
14 FOXA1 Forkhead box A1 3 3.4 
13 FOXO1 Forkhead box O1 44 2.6 
6 FOXO3 Forkhead box O3 68 1.9 
X FOXO4 Forkhead box O4 6 2.1 
19 FUT2 Fucosyltransferase 2 6 2.5 
X G6PD Glucose-6-phosphate dehydrogenase 2 8.1 
17 GH1 Growth hormone 1 1 6.6 
5 GHR Growth hormone receptor 100 3.0 
20 GHRH Growth hormone releasing hormone 6 1.8 
7 GHRHR Growth hormone releasing hormone 
receptor 
14 1.5 
11 HBB Haemoglobin β 0 NA 
5 HK3 Hexokinase 3 13 1.4 
11 HRAS Harvey rat sarcoma viral oncogene 
homolog 
5 1.7 
12 IFNg Interferon γ 6 1.7 
6 IFNGR1 Interferon γ receptor 1 7 3.8 
21 IFNGR2 Interferon γ receptor 2 19 2.1 
12 IGF1 Insulin-like growth factor 1 32 2.8 
15 IGF1R Insulin-like growth factor 1 receptor 166 1.9 
7 IGFBP3 Insulin-like growth factor binding protein 3 6 2.3 
2 IL1A Interleukin 1α 8 2.1 
2 IL1B Interleukin 1β 6 2.0 
2 IL1F10 Interleukin 1 family member 10 10 1.3 
2 IL1RN Interleukin 1 receptor antagonist 13 1.6 
4 IL2 Interleukin 2 3 3.3 
X IL2RG Interleukin 2 receptor γ 2 4.6 
5 IL4 Interleukin 4 8 1.7 
  



























































































































16 IL4R Interleukin 4 receptor 27 2.1 
5 IL5 Interleukin 5 6 1.2 
7 IL6 Interleukin 6 2 4.9 
8 IL7 Interleukin 7 29 2.7 
5 IL7R Interleukin 7 receptor 15 1.7 
1 IL10 Interleukin 10 13 1.8 
3 IL12A Interleukin 12A 7 1.7 
19 IL12RB1 Interleukin 12 receptor β1 14 2.3 
5 IL13 Interleukin 13 0 NA 
6 IL17A Interleukin 17A 6 1.5 
2 IL18RAP Interleukin 18 receptor accessory protein 23 1.7 
14 IL25 Interleukin 25 1 3.6 
2 IL36RN Interleukin 36 receptor antagonist 3 3.7 
2 IL37 Interleukin 37 6 1.8 
11 INS-IGF2 INS-IGF2 read-through gene 21 1.8 
19 INSR Insulin receptor 117 1.6 
X IRAK1 Interleukin-1 receptor-associated kinase 1 0 NA 
12 IRAK4 Interleukin-1 receptor-associated kinase 4 16 2.2 
2 IRS1 Insulin receptor substrate 1 35 2.1 
13 IRS2 Insulin receptor substrate 2 23 1.6 
9 JAK2 Janus kinase 2 53 2.8 
2 KDM3A Lysine (K)-specific demethylase 3A 33 1.7 
19 KIR3DL1 Killer cell immunoglobulin-like receptor, 
three domains, long cytoplasmic tail 1 
3 6.4 
19 KIR3DL3 Killer cell immunoglobulin-like receptor, 
three domains, long cytoplasmic tail 3 
5 3.4 
12 KMT2D Lysine (K)-specific methyltransferase 2D 14 2.4 
4 LEF1 Lymphoid enhancer-binding factor 1 74 1.7 
1 LEPR Leptin receptor 101 2.2 
19 LILRA3 Leukocyte immunoglobulin-like receptor 
subfamily A member 3 
5 1.9 
6 LIN28B Lin-28 homolog B 37 3.5 
9 MAPKAP1 Mitogen-activated protein kinase associated 
protein 1 
108 2.5 
10 MBL2 Mannose-binding lectin (protein C) 2 6 1.9 































































































































20 MCM8 Minichromosome maintenance 8 
homologous recombination repair factor 
23 2.2 
1 MTOR Mechanistic target of rapamycin 81 2.0 
3 MYD88 Myeloid differentiation primary response 
88 
5 1.9 
11 MYO7A Myosin VIIA 1 87.0 
8 NCOA2 Nuclear receptor coactivator 2 123 2.4 
14 NFKBIA Nuclear factor of κ light polypeptide gene 
enhancer in B-cells inhibitor α 
7 1.2 
8 NKX3-1 Homeobox Nkx-3.1 3 3.1 
1 NR0B2 Nuclear receptor subfamily 0 group B 
member 2 
2 3.8 
19 NR1H2 Nuclear receptor subfamily 1 group H 
member 2 
6 1.9 
11 NR1H3 Nuclear receptor subfamily 1 group H 
member 3 
8 3.1 
12 PARPBP Poly (ADP-ribose) polymerase 1 binding 
protein 
2 38.7 
2 PDK1 Pyruvate dehydrogenase kinase isozyme 1 5 13.9 
7 PDK4 Pyruvate dehydrogenase kinase isozyme 4 15 1.2 
16 PDPK1 3-phosphoinositide dependent protein 
kinase 1 
11 6.4 
19 PGPEP1 Pyroglutamyl-peptidase I 6 4.9 
3 PIK3CB Phosphatidylinositol-4,5-bisphosphate 3-
kinase catalytic subunit β 
43 2.5 
5 PIK3R1 Phosphoinositide-3-kinase regulatory 
subunit 1 
40 2.0 
12 PMCH Pro-melanin-concentrating hormone 3 2.1 
5 PPARGC1B Peroxisome proliferator-activated receptor γ 
coactivator 1β 
73 1.7 
22 PRR5 Proline rich 5 44 1.7 
10 PTEN Phosphatase and tensin homolog 17 6.5 
20 PTPN1 Protein tyrosine phosphatase non-receptor 
type 1 
34 2.3 
3 PTX3 Pentraxin 3 6 4.2 
17 RARA Retinoic acid receptor α 10 5.3 
22 RBFOX2 RNA binding protein fox-1 homolog 2 92 3.1 
  



























































































































5 RICTOR RPTOR independent companion of MTOR 
complex 2 
52 2.7 
8 RIPK2 Receptor-interacting serine-threonine 
kinase 2 
20 1.9 
14 RNASE3 Ribonuclease A family 3 1 5.9 
17 RPS6KB1 Ribosomal protein S6 kinase polypeptide 1 21 3.0 
17 RPTOR Regulatory associated protein of MTOR 
complex 1 
235 1.8 
18 SLC14A1 Urea transporter member 1 (Kidd blood 
group) 
24 1.4 
4 SPP1 Secreted phosphoprotein 1 2 3.9 
3 SST Somatostatin 3 2.2 
22 SSTR3 Somatostatin receptor 3 6 1.9 
17 STAT5A Signal transducer and activator of 
transcription 5A 
12 2.4 
17 STAT5B Signal transducer and activator of 
transcription 5B 
31 2.7 
19 SUV420H2 Suppressor of variegation 4-20 homolog 2 10 1.3 
6 SYCP2L Synaptonemal complex protein 2-like 66 1.4 
19 TCF3 Transcription factor 3 18 2.4 
19 TGFB1 Transforming growth factor β1 11 2.6 
17 THRA Thyroid hormone receptor α 16 2.3 
1 THRAP3 Thyroid hormone receptor associated 
protein 3 
26 3.3 
3 THRB Thyroid hormone receptor β 179 2.1 
19 TICAM1 Toll-like receptor adaptor molecule 1 10 2.1 
5 TICAM2 Toll-like receptor adaptor molecule 2 34 1.5 
11 TIRAP Toll-interleukin 1 receptor domain 
containing adaptor protein 
8 2.1 
4 TLR1 Toll-like receptor 1 4 3.4 
4 TLR2 Toll-like receptor 2 19 2.0 
4 TLR3 Toll-like receptor 3 17 1.2 
9 TLR4 Toll-like receptor 4 33 0.9 
1 TLR5 Toll-like receptor 5        20         1.9 
4 TLR6 Toll-like receptor 6 4 1.9 
X TLR7 Toll-like receptor 7 11 2.6 
X TLR8 Toll-like receptor 8 9 2.4 
3 TLR9 Toll-like receptor 9 2 5.0 
  



























































































































4 TLR10 Toll-like receptor 10 11 1.4 
6 TNF Tumour necrosis factor 1 7.8 
19 TOMM40 Translocase of outer mitochondrial 
membrane 40 homolog 
11 1.6 
9 TSC1 Tuberous sclerosis 1 22 2.6 
16 TSC2 Tuberous sclerosis 2 18 2.5 
14 TSHR Thyroid stimulating hormone receptor 104 1.9 
5 UIMC1 Ubiquitin interaction motif containing 1 51 2.1 
22 USP41 Ubiquitin specific peptidase 41 1 4.0 
Candidate genes included in the analyses are given with the number of SNPs associated to these genes 
included in the analyses. SNPs included as selectively neutral controls are not included in this table. An 






Chromosome Gene symbol SNP MAF OR p value 
14 AKT1 rs61758466 0.14 0.73 2.88 × 10-4 
13 IRS2 rs2026816 0.32 0.81 4.55 × 10-4 
21 CLDN14* rs2835370 0.49 1.21 5.07 × 10-4 
15 IGF1R rs2684796 0.41 0.83 7.17 × 10-4 
12 PARPBP rs17032311 0.01 2.46 9.41 × 10-4 
3 THRB rs75500315 0.02 2.08 1.18 × 10-3 
7 IL6 rs2069842 0.11 0.75 1.41 × 10-3 
6 SYCP2L rs9368446 0.03 1.62 1.44 × 10-3 
19 TCF3 rs2353219 0.20 0.79 1.54 × 10-3 
16 CLEC3A* rs430046 0.27 0.82 1.78 × 10-3 
The  analysis  was  adjusted  for  sex.  MAF:  minor  allele  frequency.  OR:  odds  ratio.  *  These  SNPs  were 
included as selectively neutral controls. The level of significance is 1.23 × 10‐5. 
  






























































































































Chromosome Gene symbol SNP MAF OR p value 
6 SYCP2L rs75788404 0.09 0.70 4.88 × 10-4 
6 ESR1 rs1293936 0.46 1.22 6.10 × 10-4 
13 IRS2 rs2026816 0.32 0.81 7.67 × 10-4 
7 IL6 rs2069842 0.11 0.74 9.15 × 10-4 
9 JAK2 rs60763646 0.10 0.74 1.27 × 10-3 
8 RIPK2 rs2158131 0.41 1.21 1.36 × 10-3 
9 JAK2 rs4372063 0.03 1.68 1.68 × 10-3 
6 SYCP2L rs57579421 0.08 0.73 1.86 × 10-3 
8 RIPK2 rs16900627 0.42 1.20 2.05 × 10-3 







Chromosome Gene symbol SNP MAF OR p value 
9 TLR4 rs10818073 0.03 1.90 4.80 × 10-4 
5 UIMC1 rs75988289 0.03 1.70 8.90 × 10-4 
13 ARHGEF7 rs74691269 0.10 1.38 9.50 × 10-4 
8 NCOA2 rs6983366 0.02 0.52 1.71 × 10-3 
3 THRB rs6785472 0.16 1.30 1.78 × 10-3 
13 ARHGEF7 rs79847747 0.09 1.36 2.09 × 10-3 
8 NCOA2 rs57293541 0.06 0.68 2.29 × 10-3 
3 THRB rs6550862 0.15 1.28 2.49 × 10-3 
5 GHR rs73085419 0.11 1.31 2.79 × 10-3 
1 CD55 rs75882193 0.02 1.92 2.85 × 10-3 
The  analysis  was  adjusted  for  sex.  MAF:  minor  allele  frequency.  OR:  odds  ratio.  The  level  of 
significance is 1.23 × 10‐5. 
  






























































































































Chromosome Gene symbol SNP MAF OR p value 
19 TGFB1 rs4803455 0.38 0.78 5.23 × 10-4 
3 THRB rs1505301 0.44 0.79 9.19 × 10-4 
17 INPP5K* rs1879488 0.23 1.27 1.68 × 10-3 
22 RBFOX2 rs916333 0.12 1.32 2.73 × 10-3 
8 NCOA2 rs16936902 0.12 1.32 3.25 × 10-3 
22 PRR5 rs2349642 0.40 1.22 3.47 × 10-3 
22 PRR5 rs2097535 0.40 1.22 3.81 × 10-3 
17 STAT5B rs9897531 0.08 1.39 4.07 × 10-3 
2 PABPCP2 rs10496971 0.07 1.38 4.64 × 10-3 






Chromosome Gene symbol SNP MAF OR p value 
2 IL1RN rs4251987 0.02 4.95 3.50 × 10-4 
15 DYX1C1 rs79593205 0.04 2.77 9.97 × 10-4 
20 PTPN1 rs77833095 0.05 0.41 1.04 × 10-3 
13 IRS2 rs74886884 0.01 7.17 1.41 × 10-3 
6 FOXO3 rs75621079 0.10 1.90 1.42 × 10-3 
17 STAT5B rs56938023 0.25 0.64 2.25 × 10-3 
6 ESR1 rs17082104 0.13 1.73 2.68 × 10-3 
15 IGF1R rs75090574 0.04 2.61 2.71 × 10-3 
19 APOE rs1081101 0.06 0.46 3.11 × 10-3 
3 THRB rs62255856 0.15 1.63 3.45 × 10-3 
MAF: minor allele frequency. OR: odds ratio. The level of significance is 1.23 × 10‐5. 
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Supplementary Figure 1. A post hoc calculation of this study’s power, depending
on  the  strength  of  the  SNP’s  effect  and  the minor  allele  frequency.  The  effect  is
expressed  as  an  odds  ratio  (OR)  determined  using  an  additive  logistic  regression
model assessing the associations of SNPs with survival between newborns and old
individuals aged 60 and over (A), between newborns and middle‐age adults of fertile
ages from 20 through 44 years (B), and between middle‐aged adults of fertile ages
from 20 through 44 years and old individuals aged 60 years or over (C). 
 
